CAMBRIDGE, Mass., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Vericel Corporation (VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the U.S.
Credit: Getty Images. NexoBrid (anacaulase-bcdb) is now available for eschar removal in adults with deep partial thickness and/or full thickness thermal burns. NexoBrid ® (anacaulase-bcdb) is now ...